Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Compumedics Limited ( (AU:CMP) ) has shared an update.
Compumedics Limited held its Annual General Meeting on October 30, 2025, where key resolutions were voted on by shareholders. The election of Mr. Christopher Barys as a director and the adoption of the remuneration report were both carried with significant support. These outcomes reflect shareholder confidence in the company’s leadership and strategic direction, potentially strengthening its market position and stakeholder relations.
The most recent analyst rating on (AU:CMP) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Compumedics Limited stock, see the AU:CMP Stock Forecast page.
More about Compumedics Limited
Compumedics Limited operates in the medical technology industry, focusing on the development and supply of computer-based diagnostic technologies. The company primarily offers products and services related to sleep diagnostics, neurodiagnostics, and brain research, catering to healthcare providers and research institutions.
Average Trading Volume: 145,076
Technical Sentiment Signal: Buy
Current Market Cap: A$64.39M
For detailed information about CMP stock, go to TipRanks’ Stock Analysis page.